tiloshil TEMOZOLOMIDE

Introduction to tiloshil

Tiloshil is a medication available in tablet form, primarily used to treat certain aggressive brain tumors. Tiloshil is specifically indicated for conditions such as glioblastoma multiforme and anaplastic astrocytoma, which are types of cancer affecting the brain.

Composition of tiloshil

Tiloshil contains the active ingredient Temozolomide, which belongs to a class of drugs known as alkylating agents. These agents work by adding an alkyl group to the DNA of cancer cells, causing damage that prevents the cells from growing and dividing.

Uses of tiloshil

• Treatment of glioblastoma multiforme
• Treatment of anaplastic astrocytoma

Side effects of tiloshil

• Common side effects: nausea, vomiting, fatigue
• Serious side effects: lowered blood cell counts, increased risk of infection

Precautions of tiloshil

Patients taking tiloshil should be aware that it can lower blood cell counts, increasing the risk of infections. It is not recommended for use during pregnancy due to potential harm to the unborn baby. Patients with severe bone marrow suppression should avoid using this medication.

How to Take tiloshil

Tiloshil is taken orally in tablet form. The usual starting dose for adults is 150 mg/m² once daily for five days in a 28-day cycle. It should be taken on an empty stomach, either one hour before or two hours after a meal. Always follow your doctor's instructions regarding dosage and administration.

Conclusion of tiloshil

Tiloshil, containing the active ingredient Temozolomide, is a therapeutic agent used in the treatment of aggressive brain tumors such as glioblastoma multiforme and anaplastic astrocytoma. Manufactured for its efficacy in stopping cancer cell multiplication, tiloshil is a critical medication in oncology. Patients should adhere to prescribed guidelines and consult healthcare providers for any concerns. Tiloshil remains a vital option in cancer treatment, offering hope to those affected by these challenging conditions.